Results 191 to 200 of about 4,153 (212)

Finerenone in Heart Failure

JAMA Cardiology
Sama Samankan, Taher Entezari-Maleki
openaire   +1 more source

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

European Heart Journal, 2016
Gerasimos Filippatos, Stefan D Anker, Mihai Gheorghiade   +2 more
exaly  

Finerenone Withdrawal

JACC
openaire   +1 more source

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes

New England Journal of Medicine
Rajiv Agarwal, Jennifer B Green, Hiddo J Lambers Heerspink   +2 more
exaly  

Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative Stress

Frontiers in Pharmacology, 2018
Raquel González-Blázquez, Beatriz Somoza, Marta Gil-Ortega   +2 more
exaly  

Determination of Finerenone in Finerenone Tablets by HPLC

Advances in Analytical Chemistry
openaire   +1 more source

Finerenone in Heart Failure—Reply

JAMA Cardiology
Muthiah Vaduganathan, John J. V. McMurray, Scott D. Solomon   +2 more
openaire   +1 more source

Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone – results from first‐in‐man and relative bioavailability studies

Fundamental and Clinical Pharmacology, 2016
Silvia Lentini, Roland Heinig
exaly  

Finerenone/Metformin

Reactions Weekly
openaire   +1 more source

Finerenone/spironolactone

Reactions Weekly
openaire   +1 more source